Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

239 Views

234. COVID-19: Vaccines: Saturday, 12:15 - 1:30 p.m.

Poster Session: COVID-19: Vaccines

(2363) Three-Month Safety and Immunogenicity of Bivalent SARS-CoV-2 Omicron-Containing Booster Vaccines: Interim Results From a Phase 3, Randomized, Observer-Blind, Active-Controlled Trial

Saturday, October 14, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

Ivan T. Lee, MD, PhD (he/him/his)

Director
Moderna, Inc.
Cambridge, Massachusetts, United States

Co-Author(s)

CC

Catherine A. Cosgrove, PhD

Vaccine Institute, Centre for Neonatal and Paediatric Infection, St George’s University of London
London, England, United Kingdom
PM

Patrick Moore, MRCGP

The Adam Practice and University Hospital Southampton NHS Foundation Trust
Southampton, England, United Kingdom
MB

Marcin Bula, MBBS

University of Liverpool
Liverpool, England, United Kingdom
PK

Philip Kalra, MD

Salford Royal Hospital and Northern Care Alliance NHS Foundation Trust
Salford, England, United Kingdom
PD

Paul Dargan, MBBS

Guy’s & St Thomas’ NHS Foundation Trust and King’s College London
London, England, United Kingdom
RC

Rebecca Clark, MBChB

Layton Medical Centre
Blackpool, England, United Kingdom
MB

Marta Boffito, MD, PhD, FRCP

Chelsea and Westminster Hospital NHS Foundation Trust and Imperial College London
London, England, United Kingdom
RS

Ray Sheridan, MRCP

Royal Devon University Hospital
Exeter, England, United Kingdom
CB

Claire Bethune, MBBChir

University Hospitals Plymouth NHS Trust
Plymouth, England, United Kingdom
FB

Fiona Burns, PhD

University College London
London, England, United Kingdom
DS

Dinesh Saralaya, MD

National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust
Bradford, England, United Kingdom
RN

Rhiannon Nally, FRCGP

Wansford and Kings Cliffe Practice
Wansford, England, United Kingdom
CD

Christopher J. A. Duncan, DPhil

Translational and Clinical Research Institute, Newcastle University and NIHR Newcastle Clinical Research Facility, The Newcastle upon Tyne Hospitals NHS Foundation Trust
Newcastle upon Tyne, England, United Kingdom
DC

David Chadwick, PhD

South Tees Hospitals NHS Foundation Trust, James Cook University Hospital
Middlesbrough, England, United Kingdom
AP

Adrian Palfreeman, MBBS

University Hospitals of Leicester NHS Trust
Leicester, England, United Kingdom
AS

Alberto San Francisco Ramos, FRCPath

Vaccine Institute, Centre for Neonatal and Paediatric Infection, St George’s University of London
London, England, United Kingdom
PH

Paul T. Heath, FRCPCH

Vaccine Institute, Centre for Neonatal and Paediatric Infection, St George’s University of London
London, England, United Kingdom
BG

Bethany Girard, Ph.D.

Moderna, Inc.
Cambridge, Massachusetts, United States
KS

Kristen Sellers, PhD

Moderna, Inc.
Cambridge, Massachusetts, United States
Ed

Elizabeth de Windt, MPH

Moderna, Inc.
Cambridge, Massachusetts, United States
AS

Andrea Sutherland, M.D., MPH

Moderna, Inc.
Cambridge, Massachusetts, United States
LT

LaRee Tracy, PhD

Moderna, Inc.
Cambridge, Massachusetts, United States
HZ

Honghong Zhou, Ph.D.

Moderna, Inc.
Cambridge, Massachusetts, United States
JM

Jacqueline Miller, MD

Moderna, Inc.
Cambridge, Massachusetts, United States
FP

Frances Priddy, MD, MPH

Moderna, Inc.
Cambridge, Massachusetts, United States
SC

Spyros Chalkias, MD (he/him/his)

Senior Medical Director
Moderna, Inc.
Cambridge, MA, United States
RD

Rituparna Das, M.D.

Moderna, Inc.
Cambridge, Massachusetts, United States